Chemically, it is the same as Mounjaro, with both containing the active ingredient tirzepatide, but Mounjaro is FDA-approved for the treatment of type 2 diabetes
Semaglutide and Tirzepatide weekly injections are a huge boost in jump starting your weight loss and getting results
This does not mean every new GLP-1 patient must delay surgery
The comparison between semaglutide and tirzepatide becomes especially relevant when evaluating options for complex medical situations
Zepbound (tirzepatide) is an FDA-approved weight loss drug used with a lower-calorie diet and increased physical activity to help with weight loss and long-term weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) and a weight-related health condition, such as high blood pressure, cardiovascular disease, high cholesterol, type 2 diabetes, or obstructive sleep apnea Tirzepatide, the active ingredient in Zepbound can also lower blood sugar and help people with diabetes lose weight